TVGN
NASDAQ · Biotechnology
Tevogen Bio Holdings Inc
$7.95
-1.47 (-15.61%)
Open$9.41
Previous Close$9.42
Day High$9.41
Day Low$7.79
52W High$75.50
52W Low$4.14
Volume—
Avg Volume31.7K
Market Cap39.45M
P/E Ratio—
EPS$-8.44
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+163.6% upside
Current
$7.95
$7.95
Target
$20.96
$20.96
$15.05
$20.96 avg
$24.54
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 26.00M | 22.93M | 28.87M |
| Net Income | -3,802,417 | -3,978,629 | -3,915,216 |
| Profit Margin | -14.6% | -17.4% | -13.6% |
| EBITDA | -5,256,206 | -4,739,765 | -5,087,055 |
| Free Cash Flow | -3,224,852 | -2,115,724 | -2,331,954 |
| Rev Growth | +20.6% | +0.2% | +12.7% |
| Debt/Equity | 0.27 | 0.28 | 0.30 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $213.76 | +2.08% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $330.33 | -0.13% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $130.28 | -0.17% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $429.32 | -1.15% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $641.69 | +1.81% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $293.86 | -0.15% | 66.6 | 38.43B |